ArticleBMJ open2023

Single-centre, single-blinded, randomised, parallel group, feasibility study protocol investigating if mandibular advancement device treatment for obstructive sleep apnoea can reduce nocturnal gastro-oesophageal reflux (MAD-Reflux trial).

Saoirse O'Toole et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.